IMA Condemns Maharashtra’s Course Allowing Homoeopaths to Prescribe Allopathic Medicines

The Indian Medical Association (IMA) has voiced strong opposition to the Maharashtra State Government’s introduction of the “Modern Pharmacology Certificate Course” (CCMP) for homoeopathic practitioners. The IMA claims that this initiative undermines patient safety by permitting non-allopathic doctors to prescribe allopathic medications without sufficient training.

According to the IMA, this move disregards directives issued by the High Court, which had previously called for the establishment of an inquiry committee to assess the implications of such a course. The association argues that endorsing short-term courses for prescribing medications constitutes a dangerous precedent, endangering the lives of patients.

The IMA has emphasized that both the candidates enrolled in the CCMP and the government cannot assert any “vested rights” in the matter, given that the issue is currently sub judice. “Neither the government nor the candidates can claim any rights while the matter awaits a final court order,” stated the IMA in a recent statement.

In a press conference, IMA President Dr. Santosh Kadam and Secretary Dr. Anil Awhad expressed their concerns about the government’s decision to proceed with the program during ongoing legal proceedings. They characterized this action as a violation of the integrity of modern medicine and a potential contempt of court.

Dr. Mangesh Thete, Vice President of the IMA in Maharashtra, echoed these sentiments, calling for the government to defer any implementation of the CCMP until a ruling is made by the court or the appointed inquiry committee. He stated, “Given that this matter is sub judice, it would be prudent for the government to await the court’s decision or the committee’s findings before moving forward.”

The controversy surrounding the CCMP highlights broader concerns about the regulation of medical practices in India. The IMA has long advocated for stringent standards in medical education and practice, arguing that patient safety should always be the top priority.

As the situation unfolds, the IMA continues to urge the Maharashtra State Government to reconsider its position and to prioritize the health and safety of patients over expedient solutions. The association remains steadfast in its commitment to uphold the integrity of the medical profession, emphasizing that any changes to medical training should reflect rigorous standards and comprehensive education.

The outcome of this dispute will likely have significant implications for the future of medical training and practice in Maharashtra, as well as for the relationship between different medical disciplines in India.